Atria Wealth Solutions’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.45M | Sell |
3,254
-3,402
| -51% | -$1.52M | 0.03% | 510 |
|
|
2025
Q1 | $3.23M | Sell |
6,656
-556
| -8% | -$270K | 0.04% | 463 |
|
|
2024
Q4 | $2.9M | Sell |
7,212
-2,523
| -26% | -$1.02M | 0.03% | 511 |
|
|
2024
Q3 | $4.53M | Sell |
9,735
-987
| -9% | -$459K | 0.05% | 374 |
|
|
2024
Q2 | $5.03M | Buy |
10,722
+107
| +1% | +$50.2K | 0.06% | 342 |
|
|
2024
Q1 | $4.44M | Buy |
10,615
+21
| +0.2% | +$8.78K | 0.05% | 371 |
|
|
2023
Q4 | $4.31M | Buy |
10,594
+8
| +0.1% | +$3.26K | 0.05% | 352 |
|
|
2023
Q3 | $3.68M | Buy |
10,586
+200
| +2% | +$69.5K | 0.05% | 373 |
|
|
2023
Q2 | $3.65M | Buy |
10,386
+830
| +9% | +$292K | 0.05% | 371 |
|
|
2023
Q1 | $3.01M | Buy |
9,556
+732
| +8% | +$231K | 0.04% | 405 |
|
|
2022
Q4 | $2.55M | Sell |
8,824
-776
| -8% | -$224K | 0.04% | 431 |
|
|
2022
Q3 | $2.78M | Buy |
9,600
+5,009
| +109% | +$1.45M | 0.05% | 372 |
|
|
2022
Q2 | $1.29M | Sell |
4,591
-1,435
| -24% | -$404K | 0.02% | 571 |
|
|
2022
Q1 | $1.57M | Buy |
+6,026
| New | +$1.57M | 0.03% | 557 |
|